PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study examines rate of HIV diagnosis in US

2014-07-19
(Press-News.org) The annual HIV diagnosis rate in the U.S. decreased more than 30 percent from 2002-2011, with declines observed in several key populations, although increases were found among certain age groups of men who have sex with men, especially young men, according to a study in the July 23/30 issue of JAMA, a theme issue on HIV/AIDS. The issue is being released early to coincide with the International AIDS Conference.

"There has been increasing emphasis on care and treatment for persons with human immunodeficiency virus (HIV) in the United States during the past decade, including the use of antiretroviral therapy for increasing survival and decreasing transmission. Accurate HIV diagnosis data recently became available for all states, allowing for the first time an examination of long-term national trends. These data can be used to monitor awareness of serostatus among persons living with HIV, primary prevention efforts, and testing initiatives," according to background information in the article.

Anna Satcher Johnson, M.P.H., of the Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, and colleagues examined trends in HIV diagnoses from 2002-2011 among persons ages 13 years or older in the United States, using data from the National HIV Surveillance System of the CDC. All data were collected through routine HIV surveillance mandated by laws or regulations in the 50 states and the District of Columbia.

During 2002-2011, 493,372 persons were diagnosed with HIV in the United States. The annual diagnosis rate decreased by 33.2 percent, from 24.1 per 100,000 population in 2002 to 16.1 in 2011. Statistically significant decreases in diagnosis rates over time were found in nearly every demographic population with the largest changes observed in women, persons 35-44 years of age, and persons of multiple races. Changes were not evident for Asians or Native Hawaiians/other Pacific Islanders. The annual number of HIV diagnoses decreased in persons with infection attributed to injection drug use or to heterosexual contact.

From 2002-2011, diagnoses attributed to male-to-male sexual contact remained stable overall, increasing among males 13-24, 45-54, and 55 years or older, and decreasing among males 35-44 years of age. The largest change (132.5 percent increase) was observed among males 13-24 years of age.

The authors note that because of delays in diagnosis, trends in diagnoses and variations among groups may reflect earlier changes in HIV infection rates. They add that this study is limited in that trends in diagnoses can be influenced by changes in testing patterns. "The HIV testing services were expanded during the analysis period and early outcomes of testing initiatives often indicate increases in diagnoses until some level of testing saturation occurs. Our study found overall decreases in annual diagnosis rates despite the implementation of testing initiatives during the period of analysis."

"Among men who have sex with men, unprotected risk behaviors in the presence of high prevalence and unsuppressed viral load may continue to drive HIV transmission. Disparities in rates of HIV among young men who have sex with men present prevention challenges and warrant expanded efforts." INFORMATION: (doi:10.1001/jama.2014.8534; Available pre-embargo to the media at http://media.jamanetwork.com)

Editor's Note: The CDC provides funds to all states and the District of Columbia to conduct the HIV surveillance data used in this study. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, etc.



ELSE PRESS RELEASES FROM THIS DATE:

Combination treatment for Hep C associated with favorable response among patients with HIV

2014-07-19
HIV-infected patients also infected with hepatitis C virus (HCV) who received a combination of the medications sofosbuvir plus ribavirin had high rates of sustained HCV virologic response 12 weeks after cessation of therapy, according to a study in the July 23/30 issue of JAMA, a theme issue on HIV/AIDS. The issue is being released early to coincide with the International AIDS Conference. Up to 7 million persons worldwide are infected with both human immunodeficiency virus (HIV) and hepatitis C virus. Treatment of this coinfection has been limited due to the need to ...

Offering option of initial HIV care at home increases use of antiretroviral therapy

2014-07-19
Among adults in the African country of Malawi offered HIV self-testing, optional home initiation of care compared with standard HIV care resulted in a significant increase in the proportion of adults initiating antiretroviral therapy, according to a study in the July 23/30 issue of JAMA, a theme issue on HIV/AIDS. The issue is being released early to coincide with the International AIDS Conference. In 2012, an estimated 35 million individuals were infected with the human immunodeficiency virus (HIV) worldwide. Antiretroviral therapy (ART) substantially reduces the risk ...

Study examines effect on pregnancy of receiving antiretroviral therapy for preventing HIV

2014-07-19
Among heterosexual African couples in which the male was HIV positive and the female was not, receipt of antiretroviral pre-exposure preventive (PrEP) therapy did not result in significant differences in pregnancy incidence, birth outcomes, and infant growth compared to females who received placebo, according to a study in the July 23/30 issue of JAMA, a theme issue on HIV/AIDS. The authors note that these findings do not provide a definitive conclusion regarding the safety of PrEP therapy prior to pregnancy. The issue is being released early to coincide with the International ...

Growth hormone analog may reduce risk of fatty liver disease in HIV-infected patients

2014-07-19
In a preliminary study, HIV-infected patients with excess abdominal fat who received the growth hormone-releasing hormone analog tesamorelin for 6 months experienced modest reductions in liver fat, according to a study in the July 23/30 issue of JAMA, a theme issue on HIV/AIDS. Patients infected with HIV demonstrate a high prevalence of nonalcoholic fatty liver disease, estimated at 30 percent to 40 percent. The issue is being released early to coincide with the International AIDS Conference. In human immunodeficiency virus (HIV) infection, abdominal fat accumulation ...

Offering option of initial HIV care at home increases use of ART

2014-07-19
LSTM Researchers found that offering adults in Malawi optional home initiation of care following HIV self-testing resulted in a significant increase in the proportion of adults initiating antiretroviral therapy (ART) compared with standard HIV care. The results are part of a study that was funded by the Wellcome Trust and published in the July 23/30 issue of JAMA, which is HIV/AIDS themed and released early to coincide with the International AIDS Conference taking place in Melbourne, Australia next week. In 2012 it was estimated that 35 million people worldwide were living ...

Hepatitis C cured in co-infected HIV patients

2014-07-19
A multicenter team of researchers report that in a phase III clinical trial, a combination drug therapy cures chronic hepatitis C in the majority of patients co-infected with both HIV and hepatitis C. "In many settings, hepatitis C is now a leading cause of death among HIV co-infected patients," says Mark Sulkowski, M.D., medical director of the Johns Hopkins Infectious Disease Center for Viral Hepatitis and professor of medicine at the Johns Hopkins University School of Medicine. Approximately one-third of HIV patients in the United States have hepatitis C, with an estimated ...

Feinstein Institute researchers identify brain network

2014-07-19
Manhassett, NY – Investigators at The Feinstein Institute for Medical Research have utilized a new image-based strategy to identify and measure placebo effects in randomized clinical trials for brain disorders. The findings are published in the August issue of The Journal of Clinical Investigation. Parkinson's disease is the second most common neurodegenerative disease in the US. Those who suffer from Parkinson's disease most often experience tremors, slowness of movement (bradykinesia), rigidity, and impaired balance and coordination. Patients may have difficulty walking, ...

Performance improvement program helps doctors better manage depression, reports journal of psychiatric practice

2014-07-18
A performance improvement initiative for physicians can significantly increase their use of evidence-based practices in screening for and treating depression, in the July Journal of Psychiatric Practice. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. Led by Dr Michael E. Thase of the University of Pennsylvania Medical School, the researchers evaluated a performance improvement continuing medical education (PI CME) program to increase physicians' use of practices that have been shown to improve diagnosis and care for depression. ...

NASA sees powerful thunderstorms in Tropical Storm Matmo

NASA sees powerful thunderstorms in Tropical Storm Matmo
2014-07-18
Strong thunderstorms reaching toward the top of the troposphere circled Tropical Storm Matmo's center and appeared in a band of thunderstorms on the storm's southwestern quadrant. Infrared imagery from NASA's Aqua satellite showed very cold temperatures that indicated the high cloud tops in the powerful storms. Tropical cyclones consist of hundreds of thunderstorms. When NASA's Aqua satellite flew over Tropical Storm Matmo on July 17 at 16:59 UTC (12:59 p.m. EDT) on July 17, the Atmospheric Infrared Sounder (AIRS) instrument obtained infrared data on the tropical cyclone. ...

High-dose fluticasone effective against eosinophilic esophagitis

2014-07-18
Results from a clinical trial show that high doses of the corticosteroid fluticasone propionate safely and effectively induce remission in many people with eosinophilic esophagitis (EoE), a chronic inflammatory disease of the esophagus characterized by high levels of white blood cells called eosinophils. However, some trial participants did not respond to fluticasone even after six months of high-dose treatments, providing evidence that certain people with EoE are steroid-resistant. By analyzing gene expression—the degree to which certain genes are turned on or off—in esophageal ...

LAST 30 PRESS RELEASES:

How climate change threatens this iconic Florida bird

Study reveals new factor involved in controlling calorie expenditure

Managing forests with smart technologies

Clinical trial finds that adding the chemotherapy pill temozolomide to radiation therapy improves survival in adult patients with a slow-growing type of brain tumor

H.E.S.S. collaboration detects the most energetic cosmic-ray electrons and positrons ever observed

Novel supernova observations grant astronomers a peek into the cosmic past

Association of severe maternal morbidity with subsequent birth

Herodotus' theory on Armenian origins debunked by first whole-genome study

Women who suffer pregnancy complications have fewer children

Home testing kits and coordinated outreach substantially improve colorectal cancer screening rates

COVID-19 vaccine reactogenicity among young children

Generalizability of clinical trials of novel weight loss medications to the US adult population

Wildfire smoke exposure and incident dementia

Health co-benefits of China's carbon neutrality policies highlighted in new review

Key brain circuit for female sexual rejection uncovered

Electrical nerve stimulation eases long COVID pain and fatigue

ASTRO issues update to clinical guideline on radiation therapy for rectal cancer

Mount Sinai opens the Hamilton and Amabel James Center for Artificial Intelligence and Human Health to transform health care by spearheading the AI revolution

Researchers develop tools to examine neighborhood economic effects on spinal cord injury outcomes

Case Western Reserve University awarded $1.5 million to study vaginal bacterial linked to serious health risks

The next evolution of AI begins with ours

Using sunlight to recycle black plastics

ODS FeCrAl alloys endure liquid metal flow at 600 °C resembling a fusion blanket environment

A genetic key to understanding mitochondrial DNA depletion syndrome

The future of edge AI: Dye-sensitized solar cell-based synaptic device

Bats’ amazing plan B for when they can’t hear

Common thyroid medicine linked to bone loss

Vaping causes immediate effects on vascular function

A new clock to structure sleep

Study reveals new way to unlock blood-brain barrier, potentially opening doors to treat brain and nerve diseases

[Press-News.org] Study examines rate of HIV diagnosis in US